Report cover image

Swine Vaccines Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

Publisher Global Market Insights
Published Oct 08, 2025
Length 164 Pages
SKU # GMI20513109

Description

The Global Swine Vaccines Market was valued at USD 1.4 billion in 2024 and is estimated to grow at a CAGR of 6.1% to reach USD 2.69 billion by 2034.

This robust growth is attributed to the rising prevalence of infectious diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Classical Swine Fever (CSF), and African Swine Fever (ASF), alongside growing regulatory emphasis on reducing antibiotic use in livestock production. Swine vaccines are essential tools for maintaining herd immunity, ensuring food security, and safeguarding global pork supply chains. Increasing awareness among producers about the economic benefits of preventive healthcare and the expansion of veterinary infrastructure are further fueling demand.

Based on type, the live attenuated vaccines segment generated USD 514.8 million in 2024 and is expected to reach USD 951.6 million by 2034 at a CAGR of 6.4%. These vaccines remain the preferred choice due to their ability to induce strong and long-lasting immunity by closely mimicking natural infections. The segment’s growth is reinforced by advancements in genetic engineering and attenuation technologies that enhance vaccine safety and broaden applicability across diverse disease strains.

By application, the bacterial infections segment was valued at USD 361.5 million in 2024, driven by the increasing prevalence of diseases such as swine erysipelas and Glässer’s disease. The need to reduce antibiotic reliance and regulatory encouragement for vaccination programs has further accelerated adoption. Combination vaccines offering protection against multiple bacterial pathogens are gaining popularity, minimizing the number of injections and improving compliance among farmers.

North America Swine Vaccines Market generated USD 650.8 million in 2024, projected to reach USD 1.1 billion by 2034 at a CAGR of 5.6%. The region’s dominance stems from advanced livestock management practices, strong veterinary infrastructure, and increasing efforts to reduce antimicrobial use. The U.S. stands out due to its large commercial pig production base and high pork export activity, which demand stringent disease control measures and biosecurity programs.

Key players operating in the Global Swine Vaccines Market include Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva Santé Animale, Elanco Animal Health Incorporated, and Virbac, among others. Leading companies in the Swine Vaccines Market are focusing on product innovation, geographical expansion, and strategic partnerships to strengthen their market foothold. Major players such as Zoetis, Boehringer Ingelheim, and Merck are investing in combination and mRNA-based vaccines that offer broad protection and improved efficacy. Firms are also expanding into emerging markets in Southeast Asia, Latin America, and Africa through localized vaccine strain adaptation and collaboration with regional veterinary networks. Furthermore, companies are leveraging digital herd health platforms, integrating genomic testing and farm management analytics to enhance vaccine performance and customer engagement.

Table of Contents

164 Pages
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Company revenue share analysis
1.4.2 Approach 2: Population-based approach
1.4.3 Approach 3: Parent market approach
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360 degree synopsis
2.2 Business trends
2.2.1 Regional trends
2.2.2 Type trends
2.2.3 Application trends
2.2.4 Route of administration trends
2.2.5 Distribution channel trends
2.3 CXO Perspectives: Strategic Imperatives
2.3.1 Key decision points for industry executives
2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.1.1 Supplier landscape
3.1.2 Value addition at each stage
3.1.3 Factors affecting the value chain
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.2 Expanding livestock industry and food security concerns
3.2.1.3 Advancements in vaccine technology
3.2.1.4 Increasing outbreaks of animal diseases
3.2.2 Industry pitfalls and challenges
3.2.2.1 High R&D costs & long development timelines
3.2.2.2 Cold chain infrastructure limitations
3.2.2.3 Regulatory complexity & approval delays
3.2.3 Market opportunities
3.2.3.1 mRNA & next-generation platform adoption
3.2.3.2 Thermostable vaccine development
3.2.3.3 Combination vaccine innovation
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By application
3.3.3 By route of administration
3.3.4 By distribution channel
3.4 Regulatory landscape
3.4.1 North America
3.4.1.1 U.S.
3.4.1.2 Canada
3.4.2 Europe
3.4.3 Asia Pacific
3.4.3.1 China
3.4.3.2 Japan
3.4.3.3 India
3.4.4 Latin America
3.4.5 Middle East and Africa
3.5 Vaccines technology evolution & innovation
3.5.1 Current technological trends
3.5.2 Emerging technologies
3.6 Future market trends
3.7 Pricing analysis
3.8 Patent analysis
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Boehringer Ingelheim International GmbH
4.1.2 Merck & Co. Inc.
4.1.3 Zoetis Inc,
4.2 Global company market share analysis
4.2.1 North America company market share analysis
4.2.2 Europe company market share analysis
4.2.3 Asia Pacific company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
Chapter 5 Swine Vaccines Market, By Type
5.1 Live attenuated vaccines
5.2 Inactivated/killed vaccines
5.3 Viral vector vaccines
5.4 mRNA vaccines
5.5 Other vaccines
Chapter 6 Swine Vaccines Market, By Application
6.1 Bacterial infections
6.2 Viral infections
6.3 Parasitic infections
6.4 Other applications
Chapter 7 Swine Vaccines Market, By Route of Administration
7.1 Injection vaccines
7.2 Oral vaccines
7.3 Immersion/spray vaccines
Chapter 8 Swine Vaccines Market, By Distribution Channel
8.1 Veterinary hospital pharmacies
8.2 Retail pharmacies
8.3 E-commerce
Chapter 9 Swine Vaccines Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profile
10.1 Addison Biological Laboratory, Inc
10.1.1 Financial data
10.1.2 Product landscape
10.1.3 SWOT analysis
10.2 Biogénesis Bagó
10.2.1 Financial data
10.2.2 Product landscape
10.2.3 Strategic outlook
10.2.4 SWOT analysis
10.3 Bioveta, a.s.
10.3.1 Financial data
10.3.2 Product landscape
10.3.3 SWOT analysis
10.4 Boehringer Ingelheim
10.4.1 Financial data
10.4.1.1 Sales revenue, 2021-2024 (USD Million)
10.4.2 Product landscape
10.4.3 Strategic outlook
10.4.4 SWOT analysis
10.5 Ceva Santé Animale
10.5.1 Financial data
10.5.2 Product landscape
10.5.3 Strategic outlook
10.5.4 SWOT analysis
10.6 Colorado Serum Company
10.6.1 Financial data
10.6.2 Product landscape
10.6.3 SWOT analysis
10.7 Elanco Animal Health Incorporated
10.7.1 Financial data
10.7.1.1 Sales revenue, 2021-2024 (USD Million)
10.7.2 Product landscape
10.7.3 SWOT analysis
10.8 HIPRA S.A.
10.8.1 Financial data
10.8.2 Product landscape
10.8.3 SWOT analysis
10.9 Indian Immunologicals Ltd
10.9.1 Financial data
10.9.2 Product landscape
10.9.3 SWOT analysis
10.10 Merck & Co., Inc
10.10.1 Financial data
10.10.1.1 Sales revenue, 2021-2024 (USD Million)
10.10.2 Product landscape
10.10.3 Strategic outlook
10.10.4 SWOT analysis
10.11 Vaxxinova (EW Group)
10.11.1 Financial data
10.11.2 Product landscape
10.11.3 Strategic outlook
10.11.4 SWOT analysis
10.12 Vibrac 156
10.12.1 Financial data
10.12.1.1 Sales revenue, 2021-2024 (USD Million)
10.12.2 Product landscape
10.12.3 Strategic outlook
10.12.4 SWOT analysis
10.13 Zoetis Inc.
10.13.1 Financial data
10.13.1.1 Sales revenue, 2021-2024 (USD Million)
10.13.2 Product landscape
10.13.3 SWOT analysis

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us